AI Article Synopsis

  • * Case 1 showed a 19-year-old male with MTC and lung metastases who responded well to treatment, while his mother (Case 2) had a late diagnosis due to inadequate genetic counseling at age 12.
  • * The sisters of the first patient (Cases 3 and 4) were also tested; one was diagnosed with MTC and the other underwent preventive surgery that revealed MTC, underscoring the importance of genetic counseling and family history in managing MEN2

Article Abstract

Multiple endocrine neoplasia (MEN) with medullary thyroid carcinoma (MTC) is associated with rearranged during transfection (RET) mutations. The authors encountered four cases of MTC-related MEN type 2B (MEN2B) with RET codon M918T mutation in one family. Case 1 included a 19 year-old male diagnosed with MTC with lung metastases. Genetic testing revealed an RET codon M918T mutation, which indicated MEN2B. The patient responded partially to vandetanib and the disease has shown no progression in 25 months. Case 2 involved the mother of the patient in Case 1. She underwent total thyroidectomy (TT) when diagnosed with MTC-related MEN2B at 12 years of age, but was not counseled adequately. Cases 3 and 4 involved the sisters of the Case 1 patient and were assessed after Case 1 was diagnosed. Genetic testing revealed the same mutation. Case 3 was diagnosed with MTC and underwent TT. Case 4 was asymptomatic but underwent prophylactic TT; histopathologic examination revealed MTC tissue. Prophylactic TT prevented MTC from being detected at an advanced state. Genetic counseling is essential in treating MEN2B. The mother was uninformed about the genetic characteristics of MEN2B, delaying the detection of MTC in her children. The present study reaffirms the importance of family history and screening.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637842PMC
http://dx.doi.org/10.3892/mco.2021.2450DOI Listing

Publication Analysis

Top Keywords

codon m918t
12
m918t mutation
12
medullary thyroid
8
multiple endocrine
8
endocrine neoplasia
8
rearranged transfection
8
mutation family
8
ret codon
8
diagnosed mtc
8
genetic testing
8

Similar Publications

DLK1 Is Associated with Stemness Phenotype in Medullary Thyroid Carcinoma Cell Lines.

Int J Mol Sci

November 2024

Genetic Bases of Thyroid Tumour Laboratory, Division of Genetics, Department of Morphology and Genetics, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04039-032, SP, Brazil.

Medullary thyroid carcinoma (MTC) is a rare and aggressive tumor, often requiring systemic treatment in advanced or metastatic stages, where drug resistance presents a significant challenge. Given the role of cancer stem cells (CSCs) in cancer recurrence and drug resistance, we aimed to identify CSC subpopulations within two MTC cell lines harboring pathogenic variants in the two most common MEN2-associated codons. We analyzed 15 stemness-associated markers, along with well-established thyroid stem cell markers (CD133, CD44, and ALDH1), a novel candidate (DLK1), and multidrug resistance proteins (MRP1 and MRP3).

View Article and Find Full Text PDF

Context: Next-generation sequencing (NGS) analysis of sporadic medullary thyroid carcinoma (sMTC) has led to increased detection of somatic mutations, including M918T, which has been considered a negative prognostic indicator.

Objective: This study aimed to determine the association between clinicopathologic behavior and somatic mutation identified on clinically motivated NGS.

Methods: In this retrospective cohort study, patients with sMTC who underwent NGS to identify somatic mutations for treatment planning were identified.

View Article and Find Full Text PDF

Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the .

Cancers (Basel)

October 2023

Aix Marseille Univ, APHM, INSERM, MMG, La Conception University Hospital, Laboratory of Molecular Biology, Marseille, France.

Medullary thyroid cancer (MTC) is a rare disease, which can be either sporadic (roughly 75% of cases) or genetically determined (multiple endocrine neoplasia type 2, due to REarranged during Transfection germline mutations, 25% of cases). Interestingly, pathogenic variants (mainly M918T) have also been reported in aggressive forms of sporadic MTC, suggesting the importance of signalling pathways in the pathogenesis of MTC. The initial theory of codon-related MTC aggressiveness has been recently questioned by studies suggesting that this would only define the age at disease onset rather than the aggressiveness of MTC.

View Article and Find Full Text PDF
Article Synopsis
  • * Case 1 showed a 19-year-old male with MTC and lung metastases who responded well to treatment, while his mother (Case 2) had a late diagnosis due to inadequate genetic counseling at age 12.
  • * The sisters of the first patient (Cases 3 and 4) were also tested; one was diagnosed with MTC and the other underwent preventive surgery that revealed MTC, underscoring the importance of genetic counseling and family history in managing MEN2
View Article and Find Full Text PDF

Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant genetic disease caused by RET gene germline mutations that is characterized by medullary thyroid carcinoma (MTC) associated with other endocrine tumors. Several reports have demonstrated that the RET mutation profile may vary according to the geographical area. In this study, we collected clinical and molecular data from 554 patients with surgically confirmed MTC from 176 families with MEN2 in 18 different Brazilian centers to compare the type and prevalence of RET mutations with those from other countries.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!